Switch to Bictegravir/Tenofovir Alafenamide/Emtrictabine or Dolutegravir + Tenofovir Disoproxil Fumarate/Emtrictabine in Virologically Suppressed People With Human Immunodeficiency Virus: Outcomes in Real-world Setting With and Without Tenofovir Resistance
2025 · Clinical Infectious Diseases · 0 citations
https://doi.org/10.1093/cid/ciaf726